aTyr Pharma reported $-54K in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Ardelyx USD -29.77M 35.79M Mar/2026
aTyr Pharma USD -54K 25.9M Mar/2026
Biogen USD 450.8M 198.9M Jun/2026
Bristol-Myers Squibb USD 5.09B 842M Jun/2026
Cipla INR 13.88B 154.2M Sep/2026
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -9.02M 1.12M Mar/2026
CSL USD 3.13B 1.17B Dec/2025
Curis USD -12.3M 231K Sep/2023
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Grifols EUR 482.04M 7.04M Sep/2025
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Novartis USD 8.62B 2.14B Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
United Therapeutics USD 355M 11.1M Jun/2026